Cargando...
Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence
Despite great efforts in stroke research, disability and recurrence rates in ischaemic stroke remain unacceptably high. To address this issue, one potential target for novel therapeutics is the glycoprotein von Willebrand factor (vWF), which increases in thrombogenicity especially under high shear r...
Gardado en:
| Publicado en: | Thromb Haemost |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Schattauer GmbH
2018
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6193403/ https://ncbi.nlm.nih.gov/pubmed/29847840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1648251 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|